Anixa Biosciences, Inc.(ANIX)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | Baskies Arnold M Director | Purchase | +10,000 | +8.00%135,000 | $3.04 | $30,400 | View SEC filing | |
| 2025-08-04 | Titterton Lewis H jr Director | Purchase | +10,000 | +1.06%953,334 | $3.08 | $30,800 | View SEC filing | |
| 2025-07-31 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | +0.87%579,925 | $3.16 | $15,800 | View SEC filing | |
| 2025-07-21 | Baskies Arnold M Director | Purchase | +5,000 | +4.17%125,000 | $3.39 | $16,950 | View SEC filing | |
| 2025-07-15 | Titterton Lewis H jr Director | Purchase | +10,000 | +1.07%943,334 | $3.14 | $31,400 | View SEC filing | |
| 2025-07-14 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | +0.88%574,925 | $3.15 | $15,750 | View SEC filing | |
| 2025-06-05 | KUMAR AMIT Chief Executive Officer | Purchase | +10,000 | +1.79%569,925 | $2.85 | $28,500 | View SEC filing | |
| 2025-01-29 | Baskies Arnold M Director | Purchase | +5,000 | +4.35%120,000 | $2.82 | $14,100 | View SEC filing | |
| 2025-01-27 | Titterton Lewis H jr Director | Purchase | +3,000 | +0.32%933,334 | $2.94 | $8,820 | View SEC filing | |
| 2025-01-23 | Titterton Lewis H jr Director | Purchase | +2,000 | +0.22%930,334 | $3.01 | $6,020 | View SEC filing | |
| 2025-01-22 | Titterton Lewis H jr Director | Purchase | +6,000 | +0.65%928,334 | $2.59 | $15,540 | View SEC filing | |
| 2025-01-17 | Titterton Lewis H jr Director | Purchase | +10,000 | +1.10%922,334 | $2.57 | $25,700 | View SEC filing | |
| 2025-01-15 | KUMAR AMIT Chief Executive Officer | Purchase | +43,000 | +8.32%559,925 | $2.23 | $95,890 | View SEC filing | |
| 2025-01-15 | Catelani Michael President, COO, & CFO | Purchase | +9,289 | +26.38%44,500 | $2.15 | $19,971 | View SEC filing | |
| 2024-08-01 | Titterton Lewis H jr Director | Purchase | +27,226 | +3.13%896,334 | $3.09 | $84,260 | View SEC filing | |
| 2024-07-29 | Titterton Lewis H jr Director | Purchase | +8,496 | +0.99%869,108 | $3.01 | $25,568 | View SEC filing | |
| 2024-07-26 | Baskies Arnold M Director | Purchase | +5,000 | +4.55%115,000 | $3.09 | $15,450 | View SEC filing | |
| 2024-06-18 | Titterton Lewis H jr Director | Purchase | +4,000 | +0.47%860,612 | $2.68 | $10,720 | View SEC filing | |
| 2024-06-14 | Titterton Lewis H jr Director | Purchase | +405 | +0.05%856,612 | $2.70 | $1,094 | View SEC filing | |
| 2024-06-12 | Titterton Lewis H jr Director | Purchase | +7,432 | +0.88%856,207 | $2.66 | $19,749 | View SEC filing | |
| 2024-06-10 | Titterton Lewis H jr Director | Purchase | +10,738 | +1.28%848,775 | $2.52 | $27,060 | View SEC filing | |
| 2024-06-07 | Catelani Michael President, COO, & CFO | Purchase | +6,250 | +21.58%35,211 | $2.40 | $15,000 | View SEC filing | |
| 2024-06-07 | KUMAR AMIT Chief Executive Officer | Purchase | +25,000 | +5.08%516,925 | $2.41 | $60,250 | View SEC filing | |
| 2024-04-10 | Titterton Lewis H jr Director | Purchase | +15,009 | +1.82%838,037 | $3.28 | $49,230 | View SEC filing | |
| 2024-03-15 | Baskies Arnold M Director | Purchase | +10,000 | +10.00%110,000 | $3.63 | $36,300 | View SEC filing |
1-25 of 224